Aniela Montserrat Silva Nolasco | Pharmaceutical Chemistry | Excellence in Research Award

Excellence in Research Award


Aniela Montserrat Silva Nolasco

Universidad de Castilla-La Mancha, Spain


Aniela Montserrat Silva Nolasco
Affiliation Universidad de Castilla-La Mancha
Country Spain
Scopus ID
57221107566
Documents 21
Citations 23
h-index 2
Subject Area Pharmaceutical Chemistry
Event International Top Pharmaceutical Awards

Aniela Montserrat Silva Nolasco is a pharmaceutical science researcher associated with Universidad de Castilla-La Mancha, Spain. Her academic profile demonstrates research engagement in molecular pharmacology, pharmaceutical chemistry, cancer biology, and bioactive therapeutic compounds. Published studies associated with her scholarly work examine anticancer properties of argentatins, immunomodulatory activity, and translational therapeutic applications in oncology-related biomedical sciences.[1] Her research contributions are indexed through recognized academic databases including Scopus and ORCID, supporting international visibility and scientific dissemination within pharmaceutical and biomedical research communities.[2]

Abstract

This article summarizes the academic contributions and pharmaceutical research activities of Aniela Montserrat Silva Nolasco. The profile reflects scholarly involvement in cancer biology, molecular pharmacology, pharmaceutical chemistry, and translational therapeutic research involving argentatin compounds and related bioactive agents.[3] Indexed publications, DOI-linked research outputs, and collaborative scientific studies contribute to the researcher’s academic visibility within pharmaceutical and biomedical sciences.[4]

Keywords

Pharmaceutical Chemistry, Molecular Pharmacology, Anticancer Research, Argentatins, Cancer Biology, Translational Medicine, Immunomodulation, Biomedical Sciences, Oncology Research, Therapeutic Compounds.

Introduction

Pharmaceutical research associated with molecular therapeutics and cancer-related biomedical investigations continues to contribute substantially to contemporary translational medicine. Current scientific developments increasingly emphasize naturally derived compounds with potential therapeutic applications against tumor progression and immune dysregulation.[5] Research contributions associated with Aniela Montserrat Silva Nolasco demonstrate participation in this evolving pharmaceutical research landscape through investigations involving argentatins and cellular pharmacological mechanisms.[6]

Research Profile

The academic profile of Aniela Montserrat Silva Nolasco includes affiliations with Universidad de Castilla-La Mancha and previous research and educational activities associated with pharmaceutical and molecular sciences. Her scholarly background includes pharmaceutical biology, cellular pharmacology, and laboratory-based biomedical investigations relevant to therapeutic development and oncology-focused pharmaceutical sciences.[2]

The Scopus profile linked to the researcher identifies indexed publication activity, citation tracking, and collaborative research participation within pharmaceutical and biomedical disciplines. These indicators support measurable academic visibility and ongoing scholarly communication across internationally indexed scientific platforms.[1]

Research Contributions

Research contributions associated with Aniela Montserrat Silva Nolasco include investigations on argentatin compounds and their biological activity in cancer-related cellular environments. Published studies report antimigratory and antiangiogenic effects alongside analyses of long-term resistance induction associated with argentatin A and argentatin B.[3]

Additional scientific contributions address immunomodulatory activity isolated from guayule-derived compounds and synergistic therapeutic interactions involving 5-fluorouracil in colorectal cancer cell models. These studies contribute to broader translational pharmaceutical research exploring molecular therapeutic strategies in oncology-related biomedical sciences.[4]

Publications

The publication profile associated with Aniela Montserrat Silva Nolasco includes peer-reviewed research outputs indexed through recognized scientific databases. DOI-linked publications contribute to scholarly accessibility, research transparency, and international academic dissemination within pharmaceutical chemistry and molecular biomedical sciences.[3][4]

DOI-linked publications facilitate long-term accessibility and citation reliability within digital academic infrastructures. The use of persistent identifiers further supports research transparency, discoverability, and scholarly preservation across multidisciplinary scientific environments.[3]

Research Impact

Research impact is commonly evaluated using publication visibility, citation performance, indexed dissemination, and scholarly engagement across scientific communities. The researcher’s profile demonstrates documented participation in peer-reviewed pharmaceutical and biomedical research activities through Scopus-indexed publications and DOI-associated scholarly outputs.[1]

The available citation indicators and publication metrics support measurable academic relevance within specialized pharmaceutical chemistry and translational biomedical research domains. Continued scientific dissemination and collaborative publication activity may further strengthen long-term academic visibility and research influence.[2]

Award Suitability

The research activities and scholarly outputs associated with Aniela Montserrat Silva Nolasco align with the objectives of the International Top Pharmaceutical Awards through contributions to pharmaceutical chemistry, cancer-related therapeutic investigations, and molecular biomedical sciences.[6] The profile reflects participation in interdisciplinary scientific studies relevant to pharmaceutical innovation and translational therapeutic development.[3]

Conclusion

Aniela Montserrat Silva Nolasco has contributed to pharmaceutical and biomedical research through studies involving anticancer compounds, immunomodulatory activity, and molecular therapeutic investigations. Her academic profile demonstrates scholarly engagement within pharmaceutical chemistry and translational medicine, supported by indexed publications, collaborative research contributions, and DOI-linked scientific dissemination.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Aniela Montserrat Silva Nolasco, Author ID 57221107566. Scopus.https://www.scopus.com/authid/detail.uri?authorId=57221107566
  2. ORCID. (2026). Aniela M. Silva-Nolasco ORCID profile, affiliations, and academic activities.https://orcid.org/0000-0002-2134-7551
  3. Silva-Nolasco, A. M., Galvez, B. G., de la Cruz-Morcillo, M. A., & Carmona, M. (2026). Differential anti-cancer effects of argentatin A and B: antimigratory, antiangiogenic, and long-term resistance induction. Industrial Crops and Products.https://doi.org/10.1016/j.indcrop.2026.123255
  4. Silva-Nolasco, A. M., Singh, N., de la Cruz-Morcillo, M. A., GarcΓ­a-MartΓ­nez, M. M., Zalacain, A., GΓ‘lvez, B. G., & Carmona, M. (2024). Immunomodulatory activity of argentatins A and B isolated from guayule. PLOS ONE.https://doi.org/10.1371/journal.pone.0304713
  5. SΓ‘nchez‐Olivares, P., Silva‐Nolasco, A. M., de la Cruz‐Morcillo, M. A., GarcΓ­a‐MartΓ­nez, M. M., Pinedo‐Serrano, A., Carmona, M., & GalΓ‘n‐Moya, E. M. (2024). Synergistic Potential of Argentatins A and B to Improve 5‐Fluorouracil Cytotoxicity in Colorectal Cancer Cell Models. Journal of Cellular and Molecular Medicine.https://doi.org/10.1111/jcmm.70294

Shu-Rong Ban | Pharmaceutical Chemistry | Excellence in Research Award

Prof. Shu-Rong Ban | Pharmaceutical Chemistry | Excellence in Research Award

Shanxi Medical University | China

Prof. Shu-Rong Ban is a distinguished scholar in the field of medicinal chemistry with a solid academic foundation and a long-standing commitment to research, teaching, and scientific innovation. He began his academic journey at Tianjin Normal University, where he obtained his bachelor’s degree, and later pursued a combined master’s and doctoral program at Nankai University, successfully earning his doctorate. His professional career has been deeply rooted in the School of Pharmacy at Shanxi Medical University, where he advanced through the ranks from lecturer to associate professor and later professor, reflecting his dedication and contributions to the field. He also enriched his academic perspective through international exposure as a visiting scholar at McGill University in Canada and at the Beijing Institute of Technology, experiences that expanded his research horizons and fostered collaborative ties with leading researchers worldwide.Prof. Ban has been actively involved in academic leadership and professional service. He holds memberships and leadership positions in multiple professional organizations, including serving as a member of the Pharmacy Education Professional Committee of the Chinese Pharmaceutical Association, director of the Shanxi Pharmaceutical Association, deputy director of its Academic Working Committee, and director of the Shanxi Chemical Society. His academic excellence has been recognized through honors such as the Shanxi Provincial Science and Technology Progress Award, the β€œThree Educations” Advanced Individual Award of Shanxi Medical University, and the Excellent Graduate Tutor distinction, reflecting both his research achievements and commitment to education.In teaching, Prof. Ban has played a key role in shaping pharmacy education, offering undergraduate courses such as Organic Chemistry, Organic Chemistry Experiment, and Professional English, as well as postgraduate courses including Progress in Pharmacy, Introduction to the Frontier of Medicinal Chemistry, and Pharmaceutical Preparation Technology. Notably, his course on Organic Chemistry was selected as a Shanxi Provincial First-Class Course, highlighting his innovation in teaching methodology and curriculum design.

Profile: Orcid

Featured Publications

Guo, L., Kang, S., Liu, J., Ma, Y., Tian, Y., Wang, B., Ma, S., Li, L., Yan, L., Zhang, C., & Liu, W., et al. (2024). Activatable near-infrared fluorescent/photoacoustic probe for rapid identification of Ξ²-lactam-resistant bacteria. Microchemical Journal.

Ge, R., Song, J., Cao, Z., Ban, S., Tang, L., & Li, Q. (2024). Discovery of 6-acylamino/sulfonamido benzoxazolone with IL-6 inhibitory activity as promising therapeutic agents for ulcerative colitis. Chemistry & Biodiversity.

Liu, J., Li, X., Xie, S., Ma, R., Wang, H., Ban, S., Zhang, C., & Guo, L. (2024). Fabricating a PDA-NOate@CuS coated NIR-activatable titanium implant to realize simultaneous antiinfection and osseointegration. New Journal of Chemistry.

Yao, J., Li, C., Feng, J., Wei, B., Xing, R., Ban, S., Tang, L., & Liu, B. (2024). Mn-doped CeOβ‚‚ nanorods for the colorimetric sensing of glutathione. ACS Applied Nano Materials.

Liu, Y., Fu, Z., Yang, C., Luo, M., Ban, S., & Wang, S. (2024). Rh(III)-catalyzed aminoalkylation of alkenes with diazo compounds toward functionalized isoindolinones. Chinese Journal of Organic Chemistry.

Meng, S., Cao, Z., Bai, H., Ge, R., Ban, S., Tang, L., & Li, Q. (2023). Antinociceptive action of 4-(5β€²-dimethylamino)-naphthalenesulfonyl-2(3H)-benzoxazolone (W3D) on animal models of pain via inhibitory effects on NO and iNOS. Natural Product Communications.

Li, G., Zhang, H., Zhang, G., Wei, B., Liu, B., Song, H., Li, Q., & Ban, S. (2023). Asymmetric synthesis of spiropyrazolone-fused dihydrofuran-naphthoquinones bearing contiguous stereocenters via a Michael addition/chlorination/nucleophilic substitution sequence. Journal of Organic Chemistry.

Shobha Singh | Pharmaceutical Chemistry | Pharmaceutical Excellence Award

Shobha Singh | Pharmaceutical Chemistry | Pharmaceutical Excellence Award

Prof. Dr. Shobha Singh, Hygia Institute of Pharmaceutical Education and Research, Lucknow, India

Prof. Dr. Shobha Singh is a distinguished academic and researcher in pharmaceutical sciences, currently serving at Hygia Institute of Pharmaceutical Sciences, Lucknow 🏫. With a Ph.D. from AcSIR–CSIR-NBRI (2022) and a specialization in Pharmaceutical Chemistry πŸ’Š, she brings over a decade of teaching and 6 years of research experience. Her expertise spans synthetic organic chemistry, phytochemistry, and heterocyclic compound synthesis πŸ”¬. A member of IPGA and the Society of Ethnopharmacology 🌱, she has guided numerous M. Pharm. theses and contributed to international conferences. Her passion and innovation continue to drive excellence in drug research and development.

Publication Profile

Orcid

Education

Prof. Dr. Shobha Singh has pursued a strong academic path in the field of pharmaceutical sciences πŸ“š. She earned her Ph.D. from AcSIR, CSIR-NBRI, Lucknow, with a CGPA of 7.42 πŸ§ͺ. She completed her M. Pharm. in Pharmaceutical Chemistry from Uttar Pradesh Technical University in 2008 with an impressive 80.30% 🧬. Her B. Pharm. was accomplished at Northern India Engineering College in 2006 with 65.83% πŸ“–. Prior to that, she excelled in her Intermediate (1999) and High School (1997) from U.P. Board with 70% marks in both πŸŽ―β€”showcasing a consistent academic record πŸ“ˆ.

Experience

Prof. Dr. Shobha Singh brings over a decade of valuable teaching experience in pharmaceutical sciences πŸŽ“. She began her academic journey as a Lecturer at the Rameshwaram Institute of Technology and Management, Lucknow, from July 23, 2008, to April 2011 🏫. She then served as an Assistant Professor at Sherwood College of Pharmacy, Barabanki, from August 16, 2011, to January 16, 2014 πŸ§ͺ. Currently, she continues to educate and guide M. Pharm. students specializing in Pharmaceutical Chemistry πŸ’Šβ€”inspiring future researchers and professionals with her deep subject expertise and mentorship 🌟.

Awards

Prof. Dr. Shobha Singh has marked her journey with notable academic and professional achievements πŸ†. She holds a prestigious lifetime membership with the Indian Pharmacy Graduates’ Association (I.P.G.A.) 🧬 and is also a proud member of the Society of Ethnopharmacology 🌿, reflecting her commitment to advancing traditional and modern pharmaceutical sciences. Her academic excellence is further highlighted by qualifying the GATE examination twice, in 2006 and 2009 πŸŽ“, and the GPAT examination in 2013 πŸ“˜. These accolades not only signify her academic rigor but also her dedication to continuous professional growth and research excellence πŸ“ˆ.

Research Focus

Prof. Dr. Shobha Singh’s research focus lies at the intersection of phytochemistry, pharmaceutical chemistry, and natural product pharmacology 🌿πŸ§ͺ. She specializes in the phytochemical investigation and biological evaluation of medicinal plants such as Ajuga parviflora, Sesbania sesban, and Sesbania grandiflora 🌸. Her work spans the synthesis of novel heterocyclic compounds, antioxidant activity, and in silico and in vivo pharmacological screening, particularly for anticonvulsant and anticancer properties 🧬πŸ’₯. She integrates traditional knowledge with modern techniques like molecular docking, enhancing drug discovery from natural sources πŸ”πŸŒ. Her research supports innovation in plant-based drug development.

Publication Top Notes

Phytochemical and pharmacological evaluation of Ajuga parviflora Benth

Synthesis and in silico and in vivo anticonvulsant activities of substituted 2-phenyl indole derivatives

Phytochemical investigation and in-vitro antioxidant activity of Sesbania sesban and Sesbania grandiflora seeds

Akhlesh Kumari | Pharmaceutical Chemistry | Best Researcher Award

Akhlesh Kumari | Pharmaceutical Chemistry | Best Researcher Award Β 

Mrs. Akhlesh Kumari, IFTM University Moradabad, India

Mrs. Akhlesh Kumari πŸ“šπŸ‘©β€πŸŽ“ is a dedicated academician with 8 years of teaching experience and pursuing Ph.D. in Pharmaceutical Chemistry πŸ“Š. With an M. Pharm from Central University, Rajasthan πŸŽ“, she has published 4 research papers πŸ“„ and filed 3 patents πŸ“. Her research focuses on Pharmaceutical Chemistry πŸ”¬, contributing to the field’s advancement. Mrs. Kumari’s commitment to education and research makes her a promising figure in her field 🌟. With a citation index of 13 πŸ“ˆ, she demonstrates her impact on the research community. Her work showcases her potential as a leading researcher πŸ”.

Publication Profile

Google ScholarΒ 

Education

Mrs. Akhlesh Kumari is a dedicated academician with a strong background in pharmaceutical sciences πŸ“š. With 8 years of teaching experience πŸ“, she has established herself as a knowledgeable educator. Currently, she is pursuing her Ph.D. from IFTM University, Moradabad, India πŸŽ“, further enhancing her expertise. She holds an M. Pharm degree in Pharmaceutical Chemistry from Central University, Rajasthan, India 🏫. Her academic pursuits demonstrate her commitment to advancing knowledge in her field πŸ”¬. With a passion for teaching and research, Mrs. Kumari is poised to make significant contributions to pharmaceutical sciences.

Professional Memberships

Mrs. Akhlesh Kumari’s professional affiliations are currently focused on her academic and research pursuits πŸ“š. Although she doesn’t hold any specific professional memberships 🀝, her dedication to her field is evident through her teaching and research endeavors. As she continues to grow in her career, potential memberships in professional organizations could further enhance her networking opportunities and contributions to pharmaceutical sciences 🌐. For now, her commitment to education and research remains a priority, driving her to make meaningful impacts in her field πŸ”¬.

Research Focus

Mrs. Akhlesh Kumari focuses her research on organic synthesis, particularly the development of heterocyclic compounds and transition metal-catalyzed reactions such as Ruthenium-catalyzed oxidative annulation. Her work explores the design of novel antimicrobial agents, including thymol-derived chalcones and benzotriazoles, integrating computational studies to understand structure-activity relationships. This research is crucial in the development of new pharmaceutical compounds with potential biological activity. Her studies bridge synthetic organic chemistry and medicinal chemistry, targeting antimicrobial resistance and innovative drug discovery strategies.

Publication Top Notes

Ruthenium‐catalyzed oxidative annulation of anilines using benzothiazole as a removable directing group

Synthesis, computational studies of new thymol derived chalcones and their benzotriazoles as antimicrobial agents

Shah Nawaz Khan | Pharmaceutical Chemistry | Best Researcher Award

Shah Nawaz Khan | Pharmaceutical Chemistry | Best Researcher Award

Dr. Shah Nawaz Khan, Shanghai Jiao Tong University, China

Dr. Shah Nawaz Khan, Ph.D. is a distinguished pharmaceutical chemist at Shanghai Jiao Tong University, specializing in organic synthesis, medicinal chemistry, and chemical biology. With a Ph.D. in Pharmaceutical Chemistry, his research spans photocatalytic decarboxylation, transition metal catalysis, and drug discovery. He has led projects on nucleoside antibiotics, shikonin derivatives, and natural product synthesis, contributing to cutting-edge solutions in biomedical innovation. Dr. Khan has an impressive publication record in high-impact journals and actively collaborates on international research initiatives.

Publication Profile

Orcid

Education

Dr. Shah Nawaz Khan πŸŽ“ is a highly accomplished scholar in pharmaceutical sciences. He earned his Ph.D. in Pharmaceutical Chemistry from the School of Pharmacy, Shanghai Jiao Tong University πŸ‡¨πŸ‡³ (2016–2022). Prior to that, he completed his M.Phil. in Organic Synthesis at the University of Malakand πŸ‡΅πŸ‡° (2012–2014), following his Doctor of Pharmacy degree from Gomal University (2004–2009). His academic journey began with an F.Sc. in Pre-Medical (2002–2004) and Matriculation in Science (2001–2002), both from Oxford Education Academy 🏫 in KPK, Pakistan. His strong educational foundation reflects a deep commitment to pharmaceutical research and academic excellence πŸ”¬πŸ“š.

Experience

Dr. Shah Nawaz Khan πŸ”¬ has extensive research experience in medicinal and pharmaceutical chemistry. Since Nov 2022, he has been a Postdoctoral Fellow at the School of Chemistry and Chemical Engineering, SJTU πŸ‡¨πŸ‡³, working on projects like the total synthesis of natural products (GR24), Ullmann coupling, and nucleoside synthesis. His Ph.D. (2016–2022) at SJTU focused on photocatalytic decarboxylative C-O, C-C, and C-N functionalization 🌟, using photoredox and transition metal catalysis. During his M.Phil. (2012–2014) at UOM πŸ‡΅πŸ‡°, he explored pharmacological activities and synthesized amide derivatives through one-pot reactions. His work bridges synthetic innovation and biological significance πŸ§ͺπŸ’Š.

Awards

Dr. Shah Nawaz Khan πŸ… has been honored with several awards and certificates recognizing his academic, professional, and extracurricular contributions. He received certificates of appreciation for workshops and seminars on faculty development, allied health sciences, and nursing (2020–2022) πŸŽ“. He earned a Personal Protective Equipment Training certificate during the COVID-19 pandemic 🦺 and was awarded the prestigious CSC Type A Scholarship πŸ‡¨πŸ‡³ in 2016. Earlier, he participated in the β€œGSK Gold Challenge” (2010), organized national-level declamation contests (2008), and alumni events (2007) πŸ—£οΈ. Additionally, he holds over 10 sports certificates πŸ†, reflecting a well-rounded and active educational journey.

Research Focus

Dr. Shah Nawaz Khan’s research centers on pharmaceutical chemistry and medicinal compound development, particularly emphasizing anticancer, antimicrobial, and antiviral agents. His work explores naphthoquinone derivatives, cyclopeptides, and photocatalytic processes, aiming to discover novel bioactive compounds for drug discovery and skin therapies. Additionally, he contributes to the understanding of molecular mechanisms of action and synthetic methodologies in organic chemistry. His research spans diverse fields including pharmacology, biotechnology, and chemical engineering, reflecting a multidisciplinary approach toward innovative therapeutic solutions. πŸŒ±πŸ’ŠπŸ§¬ His cutting-edge investigations significantly impact disease treatment, drug design, and biomedical science.

Publication Top Notes

Exploiting the Anticancer, Antimicrobial and Antiviral Potential of Naphthoquinone Derivatives: Recent Advances and Future Prospects

A comprehensive study on the effects of annular protrusion for cavitation intensification in Venturi tubes

Exploiting the Anticancer, Antimicrobial and Antiviral Potential of Naphthoquinone Derivatives: Recent Advances and Future Prospects

Discovery of A Novel Cyclopeptide as Tyrosinase Inhibitor for Skin Lightening

Synthesis and germination activity study of novel strigolactam/strigolactone analogues

Decarboxylative oxidation-enabled consecutive C-C bond cleavage

Decarboxylative oxidation enabled consecutive C-C bond cleavage

Synthesis, characterization and antinociceptive activities of Novel 2-(2,4-dichlorophenyl)-4H-chromen-4-one

Pharmacological Activities and One Pot Two Step Synthesis of Novel (E)-N-(1-methyl-4-oxoimidazolidin-2-ylidene)benzamide

Amedea B. Seabra | Pharmaceutical Chemistry | Excellence in Research

Amedea B. Seabra | Pharmaceutical Chemistry | Excellence in Research

Assoc. Prof. Dr Amedea B. Seabra, Universidade Federal do ABC, Brazil

Assoc. Prof. Dr. Amedea B. Seabra is a renowned researcher in Chemistry at Universidade Federal do ABC (UFABC), Brazil. With a Ph.D. from UNICAMP, she specializes in biomaterials, nitric oxide release, and drug delivery systems. Her research includes developing novel materials for medical applications, such as nitric oxide-releasing hydrogels and vascular prostheses. Dr. Seabra has contributed significantly to projects related to wound healing and cardiovascular health. She has received numerous accolades, including recognition in global scientific databases and awards for her work on antimicrobial silver nanoparticles. πŸŒŸπŸ”¬πŸ’‰πŸ“šπŸŒ

Publication Profile

Google Scholar

Academic ExcellenceΒ 

Assoc. Prof. Dr. Amedea B. Seabra holds a PhD in Chemistry from Universidade Estadual de Campinas (UNICAMP) and completed postdoctoral research at Concordia University and UNICAMP. Specializing in the controlled release of drugs, biomaterials, and nitric oxide chemistry, she has made significant contributions to both basic and applied sciences. Dr. Seabra’s work bridges the gap between research and practical applications, particularly in advancing drug delivery systems and exploring innovative biomaterials. Her research continues to have a profound impact on the development of therapeutic strategies for various medical challenges. πŸ§ͺπŸ’ŠπŸ”¬πŸŒ

Professional EngagementΒ 

Assoc. Prof. Dr. Amedea B. Seabra is a distinguished academic with a wealth of experience in the field of biotechnology. Currently, she serves as the Vice Coordinator at the UFABC Graduate Program in Biotechnology and works as a collaborative researcher at the University of Edinburgh. Dr. Seabra has actively contributed to various international projects, including the prestigious Newton Advanced Fellowship. Her dedication to advancing research and fostering global collaborations highlights her commitment to scientific progress. πŸŒπŸ”¬πŸ‘©β€πŸ”¬πŸ’‘

Awards and RecognitionΒ 

Assoc. Prof. Dr. Amedea has made remarkable contributions to the scientific community, earning widespread recognition for her work. She was included in the prestigious Top 100,000 Scientists by C-Score and named among the most influential scientists globally in 2023 by Elsevier and Stanford University. Her exceptional achievements reflect her dedication and impact in her field. πŸŒπŸ”¬πŸ“šπŸŒŸ Her ongoing research continues to inspire and drive advancements, solidifying her place as a leading figure in the scientific world. πŸ‘©β€πŸ”¬βœ¨

Research Focus

Assoc. Prof. Dr. Amedea B. Seabra’s research focuses on nanotechnology, particularly the toxicology and antimicrobial properties of nanoparticles. Her studies investigate the synthesis, characterization, and biological effects of metal nanoparticles, such as silver and copper, including their cytotoxicity, genotoxicity, and environmental hazards. She has explored the potential of biogenically synthesized nanoparticles and their application in medicine, such as antimicrobial activity and toxicity in model organisms. Her work extends to the use of cellulose nanocrystals in medicine and addresses the risks posed by metal oxide nanoparticles. Overall, her research contributes to the safe application of nanomaterials. 🧬πŸ§ͺβš›οΈ

Publication Top Notes

Silver nanoparticles: A new view on mechanistic aspects on antimicrobial activity

Nanotoxicity of graphene and graphene oxide

Silver nanoparticles: a brief review of cytotoxicity and genotoxicity of chemically and biogenically synthesized nanoparticles

Green tea extract mediated biogenic synthesis of silver nanoparticles: Characterization, cytotoxicity evaluation and antibacterial activity

In vitro antifungal efficacy of copper nanoparticles against selected crop pathogenic fungi

Silver nanoparticles: Toxicity in model organisms as an overview of its hazard for human health and the environment

S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance

Antimicrobial activity of biogenic silver nanoparticles, and silver chloride nanoparticles: an overview and comments

Biogenic nanoparticles: copper, copper oxides, copper sulphides, complex copper nanostructures and their applications

Thermal and photochemical nitric oxide release from S-nitrosothiols incorporated in Pluronic F127 gel: potential uses for local and controlled nitric oxide release